期刊文献+

组织芯片技术的进展及其应用

下载PDF
导出
摘要 组织芯片技术自提出以来 ,发展迅速 ,应用前景广阔。本文对其概念、分类、构建技术 ;其在扩增癌基因的筛选、寻找与肿瘤的发生、发展。
作者 王杨 陈茂怀
出处 《汕头大学医学院学报》 2004年第3期185-186,192,共3页 Journal of Shantou University Medical College
基金 广东省科技计划项目 (2 0 0 2C30 31 6) 广东省医学科学技术研究基金 (A2 0 0 2 4 2 2 )
  • 引文网络
  • 相关文献

参考文献21

  • 1Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high-throughput molecular profiling of tumor specimens[J].Nat Med,1998,4:844-847.
  • 2周小鸽,张劲松,张小平,张野,Kristian Sandvej,Stephen J Hamilton-Dutoit.组织芯片[J].中华病理学杂志,2002,31(1):70-72. 被引量:85
  • 3Battifora H.The multitumor(sauage)tissue block:novel method for immunohistochemical antibody testing[J].Lab Invest,1986,55:244-248.
  • 4韩瑞刚,张建中,黄英武,郑燕华,赵尔增,周金莲,张卫国.肺癌石蜡包埋组织及新鲜标本组织芯片制备方法学探讨[J].临床与实验病理学杂志,2002,18(4):404-407. 被引量:17
  • 5Kallioonic MO,Wagner V,Kanonon J,et al.Tissue microarray technology for high-throughput molecular profiling of cancer[J].Hum Mol Geneitics,2001,10:657-662.
  • 6Gulmann C,Butler D,Kay E,et al.Biopsy of a biopsy:validation of immunoprofiling in gastric cancer biopsy tissue microarrays[J].Histopathology,2003,42(1):70-76.
  • 7Bubendorf L,Kononen J,Koivisto P,et al.Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays[J].Cancer Res,1999,59:803-806.
  • 8Camp RL,Charette LA,Rimm DL.Validation of tissue microarray technology in breast carcinoma[J].Lab Invest,2001,80:1 943-1 949.
  • 9Hoos A,Cordon CC.Tissue Microarray Profiling of Cancer Specimens and Cell Lines:Opportunities and Limitations[J].Laboratory Investigation,2001,81:1 331-1 338.
  • 10Chen W,Foran DJ,Reiss M,et al.Unsupervised imaging,registration and archiving of tissue microarrays[J].Proc AMIA Symp,2002(1):136-139.

二级参考文献26

  • 1洪明晃 闵华庆 见:闵华庆 主编.鼻咽癌临床分期[A].见:闵华庆,主编.鼻咽癌研究[C].广东:广东科技出版社,1998.178-190.
  • 2Moch H Kononen T K allionemi OP et al Tissue microarrays what will they bring to lolecular abnd abatuomic pathology ?Adv Anat Patol 2001,8:14-20
  • 3Ekins R,Chu FW. Microarrays: their origins and applications. Trends Biotechnol, 1999, 17, 217-218.
  • 4Wooster R. Cancer classification with DNA microarrays is less more? Trends Genet, 2000, 16:327-329.
  • 5Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res,2000,60:6617-6622.
  • 6Richter J, Wagner U, Kononen J. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol, 2000,157:787-794.
  • 7Barlund M, Monni O, Kononen J, et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. CancerRes, 2000,60:5340-5344.
  • 8Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res,1999, 59:803-806.
  • 9Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol,1999,154:981-986.
  • 10Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res,1999,5:1966-1975

共引文献111

;
使用帮助 返回顶部